Ignite Creation Date:
2024-05-06 @ 2:48 PM
Last Modification Date:
2024-10-26 @ 1:37 PM
Study NCT ID:
NCT04432259
Status:
NOT_YET_RECRUITING
Last Update Posted:
2020-06-16
First Post:
2020-06-12
Brief Title:
Oral Dexamethasone as an Intervention for Postoperative Pain and Nausea Management in Total Knee Arthroplasty
Sponsor:
Henry Ford Health System
Organization:
Henry Ford Health System
Study Overview
Official Title:
Oral Dexamethasone as an Intervention for Postoperative Pain and Nausea Management in Total Knee Arthroplasty
Status:
NOT_YET_RECRUITING
Status Verified Date:
2020-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to determine if oral dexamethasone provides clinically significant improvement in postoperative outcomes specifically nausea and pain scores
Detailed Description:
Protocols in perioperative pain management during total joint arthroplasty TJA have contributed to early discharge after surgery As practices move to favor ambulatory surgery in total joint arthroplasty changes must be made to postoperative pain and nausea management Spinal anesthesia has been essential in managing associated ambulatory TJA however nausea and vomiting are known detrimental side effects The use of systemic steroids has also been shown in the literature to reduce pain scores length of stay the need for antiemetics and increase the distance of ambulation without increasing the rate of surgical site infection or prosthetic joint infection As more same-day total joint replacement is incorporated into practice an oral alternative may prove beneficial
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None